FDA Investigator Gerald B Seaborn, Jr

Gerald B Seaborn, Jr has inspections in 13 countries as of 15 Sep 2023. Gerald B Seaborn, Jr has collaborated with a combinined 4600 experts on various inspections, contributing to compliance and improvement across diverse sectors.

Investigator Details

Number of Inspected Sites:
32
Last Inspection Date:
15 Sep 2023
Investigator Role:
FDA Investigator
Redica ID:
100007503
Country:
United States of America, United Kingdom of Great Britain and Northern Ireland, Netherlands, Turkey, Belgium, Italy, Switzerland, Finland, France, China, Germany, Japan, Czechia
Co-Investigator(s):
Adam R Cooke, Adetutu M Gidado, Alice S Tsao, Alicia M Mozzachio, Anastasia G Lolas, Anissa M Cheung, Ann Marie Montemurro, Ann Marie Schofield, Annet R Rajan, Anthony F Lorenzo, Anthony W Lee, Arsen Karapetyan, Ashutosh Rao, PhD, Barbara J Rincon, Barbara Janine Breithaupt, Barbara M Frazier, Bo Chi, PhD, Brandon C Heitmeier, Brian R Yaun, Brooke K Higgins, Brooke K Secman, Brooke K Seeman, Bruce H Mccullough, Burnell M Henry, Candice C Mandera, Candice J Cortes, Carl A Huffman, III, Carmen Y Fisher, Carol L Rehkopf, Carole L Jones, Caryn M Mcnab, Catherine J Laufmann, CDR Ileana Barreto Pettit, Chiang Syin, PhD, Christian D Lynch (CDL), Christopher R Czajka, Chryste D Best, Cynthia Jim, CSO, David A Oluwo, David K Lau, David M Beltran, Denise M Digiulio, Dennis Cantellops Paite, Derek S Smith, PhD, Diane T Bargo, Diane T O'bien, Diane T O'brien, Donald L Lech, Donna Ltartaglino Besone, Donna Mwilliams Hill, Douglas A Campbell, Douglas C Kovacs, Dr. Barbara D Paul, PhD, Dr. Gang Wang, PhD, Dr. Ralph M Bernstein, PhD, Edmund F Mrak, Jr, Edwin Melendez, Emest F Bizjak, Emily J Orban, Ephrem Hunde, PhD, Eric L Dong, BS, Erika V Butler, Felix Maldonado, Frances Namuswe, PhD, Francis A Guidry, George J Flynn, George Pyramides, Gwyn G Dickinson, Heika R Tait, Helen B Ricalde, Herbert M Corbello, Hongna Wang, Iram R Hassan, PhD, Ivis L Negrón, Ivis Lnegron Torres, Jacek Cieslak, PhD, Jacqueline Mdiaz Albertini, James A Beaulieu, James C Maclaughlin, James I Giefer, James L Dunnie, Jr, James W Leonette, Janet A Rajan, Janis R Armedoriz, Jean Blackston Hill, Jennifer D Hollstrom, Jessica Hankins, PhD, Jessica L Pressley, Joanne E King, Joey V Quitania, Jonathan W Chapman, Jorge L Guadalupe, Jose Acruz Gonzalez, Jose E Melendez, DDC, Jose R Hernandez, Joshua J Silvestri, Juhong Liu, PhD, Julianne C Mccullough, Julie D Bringger, Junho Pak, Justin A Boyd, Katherine E Jacobitz, Katherine Szestypalow, Kathleen M Jordan, Kelly L Anderson, Kenneth M Gordon, Kenneth Nieves, Kevin A Gonzalez, Kevin D Kallander, Kham Phommachanh, Kim Lthomas Cruse, Kristy A Zielny, Lane V Christensen, PhD, Larry K Austin, Laura Fontan, MS, Lawrence J Stringer, LCDR Chad N Thompson, LCDR Debra Emerson, Lewis K Antwi, Libia M Lugo, Lori A Holmquist, Lori A Holquist, Lori S Lawless, Lorie S Hannappel, Lucas B Leake, Luis A Dasta, Lynette P Salisbury, Madushini Dharmasena, PhD, Malgorzata G Norton, Marcus A Ray, Margarita Santiago, Maria Joselopez Barragan, PhD, Marie Bbuen Bigornia, Marion Michaelis, Mary E Storch, Matt D Suedkamp, Matthew M Henciak, Maxwell Van Tassell, PhD, Megan A Haggerty, Melanie M Walker, Melissa J Garcia, Meredith P Soehl, Investigator, Merideth K Rose, Meyer J Slobotsky, Michael A Charles, Michael E Maselli, Michael J Vardon, Michael J Verdi, Michael P Sheehan, Michael R Goga, Michael Shanks, MS, Miguel A Martinez, Mihaly S Ligmond, Mra Davism, Mra Munizn, Nadeem I Chaudhry, Nancy A Saxenian, Nancy A Saxenian Emmons, Nawab A Siddiqui, Nebil A Oumer, Nicholas A Violand, Nicole K Trudel, Noreen Muniz, Omotunde O Osunsanmi, Parul M Patel, Parul Patel Sullivan, Patricia D Stahnke, Patricia Fhughes Troost, Patrick C Klotzbuecher, Paul A Bonneau, Paul L Bellamy, Paul L Figarole, Jr, Philip F Istafanos, DMV, MS, Prabhu P Raju, Pratik S Upadhyay, DDC, Qin Xu, Quyen T Tran, Rachel C Harrington, Rebecca E Dombrowski, Rebecca Rodriguez, Regina Gibson Melton, Renee S Blosser, Reyes Candau Chacon, PhD, Richard K Vogel, Richard Ledwidge (nmi), PhD, Robert C Coleman, Robert D Tollefsen, Robert J Maffei, Robert J Martin, Robert M Tillman, Robert Rodriguez, Robin Levis, PhD, Rochelle K Kimmel, Roger F Zabinski, Ronald G Crawford, Rose M Ashley, Roy R Rinc, Russell J Glapion, Saied A Asbagh, Sangeeta M Khurana, PhD, Santos E Camara, Sarah E Mcmullen, Satheesh Thomas, Scott R Nichols, PhD, Sena G Dissmeyer, Sharon K Thoma, PharmD, Steven A Gonzales, Steven D Kehoe, Steven Fong, MS, PhD, Steven J Thurber, Steven P Donald, Susan M Jackson, Susan P Bruederle, Susant Hadman, Suzanne M Healy, Suzanne M Muchene, Swati Verma, Tamil Arasu, PhD, Temar Q Williams, Thai D Truong, Theressa B Smith, Thomas E Friel, Thomas J Arista, Thomas R Withers, Tiara Nbrown Crosen, Tiffani D Wilson, Timothy T Kapsala, Tonia F Bernard, Toyin B Oladimeji, Uduak M Inokon, Vaishali J Patel, Valshall Patel, Vesna V Stanoyevitch, Walter Fava, Walter L Fava, Wanda Y Fields, Wanda Y Honeyblue, William A Warnick, William H Linkroum, William Hallett, PhD, Xiaokuang Lai, PhD, Ying Xin Fan, PhD, Yvonne C Mcknight, Zachary L Miller, Zhihao Qiu (Peter), PhD, Zhong Li, PhD, Zhongren Wu

Gerald B Seaborn, Jr's Documents

Publish Date Document Type Title
October, 2000 FDA 483 Laboratories Serono S.A. - Form 483, 2000-10-13
November, 2001 EIR Fareva Pau - EIR, 2002-01-10
September, 2001 EIR Bio-Nucleonics Inc. - EIR, 2001-09-26
January, 2006 FDA 483 Norbrook Laboratories Limited - Form 483, 2006-01-26
June, 2003 FDA 483 Norbrook Laboratories, Ltd - Form 483, 2003-06-17
October, 2000 FDA 483 Norbrook Laboratories, Ltd - Form 483, 2000-10-19
June, 2003 EIR Norbrook Laboratories Limited - EIR, 2003-06-17
May, 2004 EIR PLIVA-Lachema a.s. - EIR, 2004-06-22
May, 2001 FDA 483 Datwyler Pharma Packaging - Form 483, 2001-05-23
November, 2004 FDA 483 Cangene BioPharma, LLC - Form 483, 2004-11-15
October, 2000 EIR Bayer Oy - EIR, 2000-10-27
January, 2006 FDA 483 Norbrook Laboratories Limited - Form 483, 2006-01-26
October, 2000 EIR Norbrook Laboratories Limited - EIR, 2000-10-19
November, 2004 FDA 483 Response Cangene BioPharma, LLC - Form 483R, 2005-01-13
November, 2004 EIR Cangene BioPharma, LLC - EIR, 2004-11-15
November, 2001 FDA 483 Pierre Fabre Medicament Production - Form 483, 2001-11-30
October, 2000 FDA 483 Response Bayer Oy - Form 483R, 2000-11-03
May, 2001 EIR Datwyler Pharma Packaging - EIR, 2001-05-23

Experience Redica System's NEW investigator profiles and dashboards

Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:

  • Total inspections conducted
  • 483 rate
  • OAI rate
  • Warning Letter rate
  • Inspections by Industry, Scope, and Inspection Reason
  • And much more

Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.

FDA Investigator Profile Icon

Talk to sales to access our investigator profiles

Loading...

Investigator Profiles Are Just the Tip of the Iceberg

Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:

Inspection Intelligence

  • Pre-Approval Inspection (PAI) trends
  • The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
  • Latest 483s: see what the trends are across all FDA Investigators
  • CFR Heatmap: Citations aggregated by Subpart by Year

Vendor Intelligence

  • Full inspection histories for your vendors down to the specific site level
  • All of the functionality mentioned above but isolated to just your vendors

Regulatory Intelligence

  • Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
  • All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more